A Case of Hepatocellular Carcinoma in a Patient with Idiopathic Forearm Arteriovenous Fistula

Introduction: We report an exceedingly rare case of hepatocellular carcinoma (HCC) associated with an idiopathic congenital forearm arteriovenous fistula (AVF). Given the absence of previous reports addressing the treatment of HCC in patients with AVF, we evaluate HCC treatment strategies...

Full description

Saved in:
Bibliographic Details
Main Authors: Sayuri Takada, Yutaka Yata, Hirotaka Ishizu, Yuma Inoue, Tomoyasu Kuroda, Shigeki Ikeda, Atsushi Jogo, Akira Yamamoto, Hiroshi Higashiyama, Norifumi Kawada
Format: Article
Language:English
Published: Karger Publishers 2025-03-01
Series:Case Reports in Gastroenterology
Online Access:https://karger.com/article/doi/10.1159/000544101
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850274772598915072
author Sayuri Takada
Yutaka Yata
Hirotaka Ishizu
Yuma Inoue
Tomoyasu Kuroda
Shigeki Ikeda
Atsushi Jogo
Akira Yamamoto
Hiroshi Higashiyama
Norifumi Kawada
author_facet Sayuri Takada
Yutaka Yata
Hirotaka Ishizu
Yuma Inoue
Tomoyasu Kuroda
Shigeki Ikeda
Atsushi Jogo
Akira Yamamoto
Hiroshi Higashiyama
Norifumi Kawada
author_sort Sayuri Takada
collection DOAJ
description Introduction: We report an exceedingly rare case of hepatocellular carcinoma (HCC) associated with an idiopathic congenital forearm arteriovenous fistula (AVF). Given the absence of previous reports addressing the treatment of HCC in patients with AVF, we evaluate HCC treatment strategies, including the appropriateness of using angiogenesis inhibitors. Case Presentation: A 74-year-old man was admitted for the evaluation of liver tumors. His medical history included a chronic, intractable idiopathic right forearm AVF, for which he had undergone multiple surgical interventions. Abdominal EOB-MRI revealed multiple small focal lesions across both liver lobes during the hepatobiliary phase, indicative of multiple HCC, and liver biopsy confirmed early-stage HCC. Considering the potential presence of additional vascular anomalies similar to the forearm AVF, local hepatic artery chemoembolization was performed. Since there is still insufficient discussion about the systemic administration of angiogenesis inhibitors to patients with vascular abnormalities such as AVF, we discuss the treatment options for HCC with AVF, including its strategies in the progressed HCC stage. Conclusion: As molecularly targeted therapies continue to evolve, recognizing the unique aspects of cases like ours is crucial. Establishing an appropriate treatment strategy for HCC patients with AVF is imperative, highlighting the need for tailored therapeutic approaches based on individual vascular profiles.
format Article
id doaj-art-3efdec3e428d4542afca79dc929ebe7b
institution OA Journals
issn 1662-0631
language English
publishDate 2025-03-01
publisher Karger Publishers
record_format Article
series Case Reports in Gastroenterology
spelling doaj-art-3efdec3e428d4542afca79dc929ebe7b2025-08-20T01:51:03ZengKarger PublishersCase Reports in Gastroenterology1662-06312025-03-0119117318310.1159/000544101A Case of Hepatocellular Carcinoma in a Patient with Idiopathic Forearm Arteriovenous FistulaSayuri TakadaYutaka YataHirotaka IshizuYuma InoueTomoyasu KurodaShigeki IkedaAtsushi Jogohttps://orcid.org/0000-0003-1974-4790Akira YamamotoHiroshi HigashiyamaNorifumi Kawada Introduction: We report an exceedingly rare case of hepatocellular carcinoma (HCC) associated with an idiopathic congenital forearm arteriovenous fistula (AVF). Given the absence of previous reports addressing the treatment of HCC in patients with AVF, we evaluate HCC treatment strategies, including the appropriateness of using angiogenesis inhibitors. Case Presentation: A 74-year-old man was admitted for the evaluation of liver tumors. His medical history included a chronic, intractable idiopathic right forearm AVF, for which he had undergone multiple surgical interventions. Abdominal EOB-MRI revealed multiple small focal lesions across both liver lobes during the hepatobiliary phase, indicative of multiple HCC, and liver biopsy confirmed early-stage HCC. Considering the potential presence of additional vascular anomalies similar to the forearm AVF, local hepatic artery chemoembolization was performed. Since there is still insufficient discussion about the systemic administration of angiogenesis inhibitors to patients with vascular abnormalities such as AVF, we discuss the treatment options for HCC with AVF, including its strategies in the progressed HCC stage. Conclusion: As molecularly targeted therapies continue to evolve, recognizing the unique aspects of cases like ours is crucial. Establishing an appropriate treatment strategy for HCC patients with AVF is imperative, highlighting the need for tailored therapeutic approaches based on individual vascular profiles. https://karger.com/article/doi/10.1159/000544101
spellingShingle Sayuri Takada
Yutaka Yata
Hirotaka Ishizu
Yuma Inoue
Tomoyasu Kuroda
Shigeki Ikeda
Atsushi Jogo
Akira Yamamoto
Hiroshi Higashiyama
Norifumi Kawada
A Case of Hepatocellular Carcinoma in a Patient with Idiopathic Forearm Arteriovenous Fistula
Case Reports in Gastroenterology
title A Case of Hepatocellular Carcinoma in a Patient with Idiopathic Forearm Arteriovenous Fistula
title_full A Case of Hepatocellular Carcinoma in a Patient with Idiopathic Forearm Arteriovenous Fistula
title_fullStr A Case of Hepatocellular Carcinoma in a Patient with Idiopathic Forearm Arteriovenous Fistula
title_full_unstemmed A Case of Hepatocellular Carcinoma in a Patient with Idiopathic Forearm Arteriovenous Fistula
title_short A Case of Hepatocellular Carcinoma in a Patient with Idiopathic Forearm Arteriovenous Fistula
title_sort case of hepatocellular carcinoma in a patient with idiopathic forearm arteriovenous fistula
url https://karger.com/article/doi/10.1159/000544101
work_keys_str_mv AT sayuritakada acaseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT yutakayata acaseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT hirotakaishizu acaseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT yumainoue acaseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT tomoyasukuroda acaseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT shigekiikeda acaseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT atsushijogo acaseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT akirayamamoto acaseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT hiroshihigashiyama acaseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT norifumikawada acaseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT sayuritakada caseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT yutakayata caseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT hirotakaishizu caseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT yumainoue caseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT tomoyasukuroda caseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT shigekiikeda caseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT atsushijogo caseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT akirayamamoto caseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT hiroshihigashiyama caseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula
AT norifumikawada caseofhepatocellularcarcinomainapatientwithidiopathicforearmarteriovenousfistula